1 |
Saghi M, InanlooRahatloo K, Alavi A, Kahrizi K, Najmabadi H. Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery. BMC Med Genomics 2022;15:89. [PMID: 35436926 DOI: 10.1186/s12920-022-01237-5] [Reference Citation Analysis]
|
2 |
Liskova A, Samec M, Koklesova L, Kudela E, Kubatka P, Golubnitschaja O. Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine. Int J Mol Sci 2021;22:2007. [PMID: 33670490 DOI: 10.3390/ijms22042007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
|
3 |
Soleimani Zakeri NS, Pashazadeh S, MotieGhader H. Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network. Biomed Res Int 2021;2021:1280237. [PMID: 34692825 DOI: 10.1155/2021/1280237] [Reference Citation Analysis]
|
4 |
Lima CADM. Towards a WPA Position Document on the Human Rights of Older Adults with Mental Health Conditions. Consortium Psychiatricum 2022;3:16-21. [DOI: 10.17816/cp150] [Reference Citation Analysis]
|
5 |
Ullah R, Park TJ, Huang X, Kim MO. Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer's pathology: Insights and therapeutic approaches from periphery. Ageing Res Rev 2021;71:101451. [PMID: 34450351 DOI: 10.1016/j.arr.2021.101451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
6 |
Zhou Y, Jia E, Sheng Y, Qiao Y, Wang Y, Shi H, Liu Z, Pan M, Tu J, Bai Y, Zhao X, Ge Q, Lu Z. Sensitive and Low-Bias Transcriptome Sequencing Using Agarose PCR. ACS Appl Mater Interfaces 2022;14:19154-67. [PMID: 35446027 DOI: 10.1021/acsami.2c02133] [Reference Citation Analysis]
|
7 |
Gavrilova S. The Evolution of Diagnostic Boundaries of Alzheimer’s Disease and Novel Therapeutic Options. Consortium Psychiatricum 2022;3:8-15. [DOI: 10.17816/cp152] [Reference Citation Analysis]
|